Drawing for SARCODE

USPTO serial 77880949

SARCODE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MARTIN, LIEF ANDREW
Law office
TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SARCODE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron Hendelman

AARON HENDELMAN WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL RDPALO ALTO, CA 94304-1050UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceuticals for the treatment of inflammatory problems and diseases; pharmaceuticals for the treatment of ocular inflammatory diseases, eye dryness and inflammation, and uveitis; pharmaceuticals for the treatment of one or more than one eye condition, eye disease, eye injury, diseases of the posterior segment including diabetic retinopathy, macular edema, macular degeneration or a combination of one or more than one eye condition, eye disease, eye injury, diseases of the posterior segment including diabetic retinopathy, macular edema and macular degeneration; pharmaceuticals for the treatment of psoriasis and eczema; pharmaceuticals for the treatment of one or more than one skin condition, skin disease, or skin injury or a combination of one or more than one skin condition, skin disease and skin injury; pharmaceuticals for the treatment of Crohn's disease; pharmaceuticals for the treatment of gastrointestinal problems and diseases; pharmaceuticals for the treatment of rhinitis and allergies; pharmaceuticals for the treatment of asthma and pulmonary problems and diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 13, 2011MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 13, 2011ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 15, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 15, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 15, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 22, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 22, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 22, 2010ALIEASSIGNED TO LIE—
Sep 8, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2010PETGPETITION TO REVIVE-GRANTED—
Sep 8, 2010PROATEAS PETITION TO REVIVE RECEIVED—
Mar 2, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 2, 2010DOCKASSIGNED TO EXAMINER—
Dec 1, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 28, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance